[go: up one dir, main page]

DK1280898T3 - Modificerede ES-celler og ES-cellespecifikt gen - Google Patents

Modificerede ES-celler og ES-cellespecifikt gen

Info

Publication number
DK1280898T3
DK1280898T3 DK01928006.4T DK01928006T DK1280898T3 DK 1280898 T3 DK1280898 T3 DK 1280898T3 DK 01928006 T DK01928006 T DK 01928006T DK 1280898 T3 DK1280898 T3 DK 1280898T3
Authority
DK
Denmark
Prior art keywords
cells
modified
specific gene
cell specific
pluripotent
Prior art date
Application number
DK01928006.4T
Other languages
English (en)
Inventor
Herve Acloque
Anne-Marie Birot
Bertrand Pain
Valerie Risson
Jacques Samarut
Original Assignee
Agronomique Inst Nat Rech
Centre Nat Rech Scient
Ecole Norm Superieure Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech, Centre Nat Rech Scient, Ecole Norm Superieure Lyon filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of DK1280898T3 publication Critical patent/DK1280898T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01928006.4T 2000-05-11 2001-04-19 Modificerede ES-celler og ES-cellespecifikt gen DK1280898T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006029A FR2808803B1 (fr) 2000-05-11 2000-05-11 Cellules es modifiees et gene specifique de cellules es
PCT/FR2001/001207 WO2001085938A1 (fr) 2000-05-11 2001-04-19 Cellules es modifiees et gene specifique de cellules es

Publications (1)

Publication Number Publication Date
DK1280898T3 true DK1280898T3 (da) 2011-05-16

Family

ID=8850125

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01928006.4T DK1280898T3 (da) 2000-05-11 2001-04-19 Modificerede ES-celler og ES-cellespecifikt gen

Country Status (14)

Country Link
US (2) US20040072169A1 (da)
EP (1) EP1280898B1 (da)
JP (1) JP2004515212A (da)
AT (1) ATE498011T1 (da)
AU (2) AU5488501A (da)
BR (1) BR0110764A (da)
CA (1) CA2408732A1 (da)
DE (1) DE60144015D1 (da)
DK (1) DK1280898T3 (da)
ES (1) ES2358731T3 (da)
FR (1) FR2808803B1 (da)
NO (1) NO331814B1 (da)
NZ (1) NZ522547A (da)
WO (1) WO2001085938A1 (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808803B1 (fr) * 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
AU2002306374B2 (en) * 2001-05-31 2008-01-24 Dainippon Sumitomo Pharma Co., Ltd. Genes with ES cell-specific expression
NZ567817A (en) 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
NZ568210A (en) 2005-11-04 2012-12-21 Novartis Vaccines & Diagnostic Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines
EP1951302A2 (en) 2005-11-04 2008-08-06 Novartis Vaccines and Diagnostics S.r.l. Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
NZ568211A (en) 2005-11-04 2011-11-25 Novartis Vaccines & Diagnostic Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
CN102755645A (zh) 2005-11-04 2012-10-31 诺华疫苗和诊断有限公司 佐剂配制的包含细胞因子诱导剂的流感疫苗
EP1945252B1 (en) 2005-11-04 2013-05-29 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising purified surface antigens prepared from influenza viruses grown in cell culture, adjuvanted with squalene
JP6087041B2 (ja) 2006-01-27 2017-03-08 ノバルティス アーゲー 血球凝集素およびマトリックスタンパク質を含むインフルエンザウイルスワクチン
FR2898909A1 (fr) * 2006-03-24 2007-09-28 Agronomique Inst Nat Rech Combinaison de marqueurs de cellules aviaires
US20100068223A1 (en) 2006-03-24 2010-03-18 Hanno Scheffczik Storage of Influenza Vaccines Without Refrigeration
GB0614460D0 (en) 2006-07-20 2006-08-30 Novartis Ag Vaccines
ES2480491T3 (es) 2006-12-06 2014-07-28 Novartis Ag Vacunas incluyendo antígeno de cuatro cepas de virus de la gripe
EA201070066A1 (ru) 2007-06-27 2010-06-30 Новартис Аг Вакцины против гриппа с низким содержанием добавок
GB0810305D0 (en) 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
EP2268309B1 (en) 2008-03-18 2015-01-21 Novartis AG Improvements in preparation of influenza virus vaccine antigens
WO2010079081A1 (en) 2009-01-07 2010-07-15 Glaxosmithkline Biologicals S.A. Methods for recovering a virus or a viral antigen produced by cell culture
EP2393922A1 (en) 2009-02-06 2011-12-14 GlaxoSmithKline Biologicals S.A. Purification of virus or viral antigens by density gradient ultracentrifugation
EA201500910A1 (ru) 2009-02-10 2016-04-29 Новартис Аг Вакцины против гриппа со сниженным количеством сквалена
CA2752041A1 (en) 2009-02-10 2010-08-19 Novartis Ag Influenza vaccines with increased amounts of h3 antigen
US20120093859A1 (en) 2009-02-10 2012-04-19 Novartis Ag Influenza vaccine regimens for pandemic-associated strains
CA2763816A1 (en) 2009-04-27 2010-11-04 Novartis Ag Adjuvanted vaccines for protecting against influenza
WO2011030218A1 (en) 2009-09-10 2011-03-17 Novartis Ag Combination vaccines against respiratory tract diseases
EP2531592A1 (en) 2010-02-04 2012-12-12 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
US9494571B2 (en) 2010-03-08 2016-11-15 Novartis Ag Methods of testing for intracellular pathogens
JP6200805B2 (ja) 2010-05-03 2017-09-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規な方法
JP6072677B2 (ja) 2010-05-06 2017-02-01 ノバルティス アーゲー 微生物の不活化のための有機ペルオキシド化合物
CN103025350A (zh) 2010-05-21 2013-04-03 诺华有限公司 流感病毒的重配方法
HUE051711T2 (hu) 2010-06-01 2021-03-29 Seqirus Uk Ltd Influenzavakcina antigénjeinek koncentrálása liofilizálás nélkül
BR112012030616A2 (pt) 2010-06-01 2017-03-01 Novartis Ag concentração de antígenos de vacina com liofilização.
ES2531577T3 (es) 2010-08-20 2015-03-17 Novartis Ag Conjuntos de agujas para la administración de vacuna soluble contra la gripe
JP2014518080A (ja) 2011-06-27 2014-07-28 バルネバ 細胞のスクリーニング方法
GB201216121D0 (en) 2012-09-10 2012-10-24 Novartis Ag Sample quantification by disc centrifugation
EP2768528A1 (en) 2011-10-20 2014-08-27 Novartis AG Adjuvanted influenza b virus vaccines for pediatric priming
GB201218195D0 (en) 2012-10-10 2012-11-21 Istituto Zooprofilattico Sperimentale Delle Venezie Composition
CA2920934C (en) 2013-08-30 2022-12-06 Glaxosmithkline Biologicals S.A. Large scale production of viruses in cell culture
EP3234113B1 (en) 2014-12-16 2019-01-23 GlaxoSmithKline Biologicals S.A. A method for a large scale virus purification
PT3233130T (pt) 2014-12-17 2021-06-24 Fundacion Para La Investig Medica Aplicada Construções de ácido nucleico e vetores para terapia génica para usar no tratamento da doença de wilson
US11118238B2 (en) 2014-12-17 2021-09-14 Fundación Para La Investigación Mèdica Aplicada Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions
EP3313439A2 (en) 2015-06-26 2018-05-02 Seqirus UK Limited Antigenically matched influenza vaccines
KR102576962B1 (ko) 2015-07-07 2023-09-11 세퀴러스 유케이 리미티드 인플루엔자 효능 검정
JP7401432B2 (ja) 2017-12-01 2023-12-19 エンコーデッド セラピューティクス， インコーポレイテッド 操作されたｄｎａ結合タンパク質
US20210180084A1 (en) 2018-05-14 2021-06-17 Vivet Therapeutics Gene therapy vectors comprising s/mar sequences
JP2022508724A (ja) 2018-10-12 2022-01-19 ヴィヴェ テラピューティクス 進行性家族性肝内胆汁鬱滞タイプ３（ｐｆｉｃ３）の治療のためのコドン最適化導入遺伝子
TW202039854A (zh) 2018-11-16 2020-11-01 美商編碼製藥公司 治療威爾遜氏病的組合物和方法
CA3141900C (en) 2019-05-29 2023-06-06 Encoded Therapeutics, Inc. Compositions and methods for selective gene regulation
CN114222818B (zh) 2019-07-02 2025-07-08 基础应用医学研究基金会 cPLA2e诱导剂及其用途
US20230000971A1 (en) 2019-11-18 2023-01-05 Seqirus Pty Ltd. Method for producing reassortant influenza viruses
EP4192961A2 (en) 2020-08-06 2023-06-14 Fundacion para la Investigacion Medica Aplicada Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy
US20230265456A1 (en) 2020-08-10 2023-08-24 Fundacion Para La Investigacion Medica Aplicada Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis
AR123756A1 (es) 2020-10-09 2023-01-11 UCB Biopharma SRL Construcciones de ácidos nucléicos, vectores virales y partículas virales
IL312340A (en) 2021-10-28 2024-06-01 UCB Biopharma SRL Nucleic acid constructs, viral vectors and viral particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
FR2726003B1 (fr) * 1994-10-21 2002-10-18 Agronomique Inst Nat Rech Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
CA2341754A1 (en) * 1998-08-31 2000-03-09 New York University Stem cells bearing an fgf receptor on the cell surface
FR2808803B1 (fr) * 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es

Also Published As

Publication number Publication date
NO331814B1 (no) 2012-04-10
US20090151013A1 (en) 2009-06-11
FR2808803A1 (fr) 2001-11-16
EP1280898A1 (fr) 2003-02-05
CA2408732A1 (fr) 2001-11-15
US20040072169A1 (en) 2004-04-15
BR0110764A (pt) 2003-05-06
AU5488501A (en) 2001-11-20
JP2004515212A (ja) 2004-05-27
FR2808803B1 (fr) 2004-12-10
ATE498011T1 (de) 2011-02-15
NO20025402L (no) 2003-01-08
DE60144015D1 (de) 2011-03-24
WO2001085938A1 (fr) 2001-11-15
AU2001254885B2 (en) 2006-08-10
NZ522547A (en) 2006-02-24
ES2358731T3 (es) 2011-05-13
EP1280898B1 (fr) 2011-02-09
NO20025402D0 (no) 2002-11-11

Similar Documents

Publication Publication Date Title
DK1280898T3 (da) Modificerede ES-celler og ES-cellespecifikt gen
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
DK1474507T3 (da) Fremgangsmåder og materialer til produktion af organiske produkter i celler af Candida arter
ATE297987T1 (de) Bedingte immortalisierung von zellen
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
ES2155702T3 (es) Construcciones expresivas halteroformes para la terapia genetica.
WO2012070014A3 (en) Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
ATE500323T1 (de) Subtilisin-variante
MX2022005093A (es) Métodos de secuenciación de proteína de una sola célula y ácido nucleico.
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
NZ538852A (en) Selection and isolation of living cells using mRNA-binding probes
WO2003080816A3 (en) Stem cell culture
ATE450620T1 (de) Stabiler kreatinin-biosensor mit drei enzymen
DK1082423T3 (da) Cyclin E2-gener og -proteiner
WO2003033673A3 (en) High-throughput transcriptome and functional validation analysis
WO2008146649A1 (ja) 酵素含有ゲル及び核酸の増幅キット
WO2004078915A3 (en) Cell culture
NO20012342L (no) Mutasjon av parkin genet, preparater, fremgangsmåter og anvendelse
ATE386140T1 (de) Methoden und reagenzien zur in situ amplifizierung
WO2000011168A3 (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
FI972909A0 (fi) Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller
DE60209137D1 (de) Verfahren zur selektion von transformierten zellen
WO2002064756A3 (en) Stem cell identification
ATE403863T1 (de) Verfahren zum nachweis von intrazellulären atp und/oder genexpression
DE50113417D1 (de) Zellbindende nukleinsäuremoleküle (aptamere)